Chronic fatigue syndrome creates conditions where pathogen-killing immune T cells become exhausted, according to a new Cornell University study.

The study’s authors knew the immune system was dysregulated in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) but wondered which parts shift with the condition.

A systematic exploration revealed that key CD8+ T cells displayed one of the most pronounced signatures of dysregulation, with signs of constant stimulation that lead to an exhausted state, a condition that is well-studied in cancer.

“This is an important finding for ME/CFS because now we can examine the T cells more car...

During your first driving class, the instructor probably sat next to you, offering immediate advice on every turn, stop and minor adjustment. If it was a parent, they might have even grabbed the wheel a few times and shouted “Brake!” Over time, those corrections and insights developed experience and intuition, turning you into an independent, capable driver.

Although advancements in artificial intelligence (AI) have made self-driving cars a reality, the teaching methods used to train them remain a far cry from even the most nervous side-seat driver. Rather than nuance and real-time instruction, AI learns primarily through massive datasets and extensive simulations, regardless of the application.

Now, researchers from Duke University and the Army Research Laboratory have develope...

The unusual system of three ‘super puff’ planets has at least one more planet, revealed by its gravitational tug on other planets. An unusual planetary system with three known ultra-low density “super-puff” planets has at least one more planet, according to new research led by researchers from Penn State and Osaka University...

Tad Carper had no idea the technology to detect more than 50 cancers with one test existed. He does now, and the Dallas Cowboys senior vice president of communication wants to help spread the word.

Carper recently underwent surgery for Stage 2 throat cancer. He exhibited no symptoms. The Galleri blood test, developed by GRAIL, allowed him to attack the cancer sooner than he would have been able to otherwise.

The story of Carper and others helps put a face on its impact and increases awareness of this relatively new technology.

“There is nothing that is more motivating and inspiring than hearing these stories,” said Dr. Josh Ofman, president of GRAIL, a California-based biotech company that specializes in early cancer detection.

Single-...